Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Reserve Bank of New Zealand: Insurance hike risk balance – ING

Reserve Bank of New Zealand: Insurance hike risk balance – ING

FXStreetFXStreet2026/07/06 13:18
By:FXStreet

ING’s Francesco Pesole expects the Reserve Bank of New Zealand (RBNZ) to deliver a 25bp ‘insurance’ hike in July, taking the policy rate to 2.50%, despite the sharp drop in Oil prices. He notes that May’s rate projections have been largely invalidated by lower Oil and softer inflation, and warns this move could end up being a one-off, limiting further New Zealand Dollar (NZD) support.

Insurance hike seen as finely balanced

"The collapse in oil prices makes the Reserve Bank of New Zealand’s 8 July decision more finely balanced. Even so, we expect policymakers to avoid disappointing hawkish pricing and deliver a 25bp ECB-style ‘insurance’ hike to anchor inflation expectations. That said, the risk of this being a one-off move is rising, which can limit NZD upside."

"Back in May, the RBNZ kept rates on hold at 2.25% in a 3-3 split decision, with Governor Anna Breman casting the tiebreaking vote. The hawks’ concerns echoed those across other developed markets: the risk of inflation expectations de-anchoring and second-round effects. Breman opted for patience, but official rate projections signalled 50-75bp of tightening by end-2026."

"But the oil assumptions underpinning those forecasts could not be more different now. The RBNZ assumed Dubai crude at around $95-105/bbl for the rest of 2026, versus current levels near $65. Accordingly, projections for headline CPI above 4.0% until 4Q26 now look unrealistic."

"We therefore expect a 25bp hike to 2.50%, akin to the ECB’s June ‘insurance’ move. We still narrowly see one more hike in 2026, but the risk of this being a one-off has increased materially."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales